Public list Pharma Startups (6570)
:ImmuneOncia seeks to develop and commercialize a number of immune checkpoint antibodies against undisclosed targets for both hematological malignancies and solid tumors.
Company (Alive / Active)
Phone: +82 (31) 306-8186
25, Tapsil-ro 35 road
Giheung-gu, Yongin-si
Gyeonggi-do, 17084
South Korea
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Title | Application Date | Patent Date | Status (Patent / Application) |
---|